Aandelen in “Biotechnologie”

Aandeel Datum Koers Evolutie
Even geduld...

Nieuws over “Biotechnologie”

17/09 · Biogen Receives European Commission Approval for ZURZUVAE® (zuranolone), the First and Only Treatment Approved for Women with Postpartum Depression in Europe · Persbericht

17/09 · Biogen Receives European Commission Approval for ZURZUVAE® (zuranolone), the First and Only Treatment Approved for Women with Postpartum Depression in Europe · Persbericht

17/09 · NANOBIOTIX Announces New Results From a Phase 1 Study Evaluating JNJ-1900 (NBTXR3) in Combination With Immune Checkpoint Inhibitors as a 2L+ Therapy for Patients With Primary Cutaneous Melanoma Resistant to Anti-PD-1 · Persbericht

16/09 · Availability of Transgene’s Half-Year Financial Report as of June 30, 2025 · Persbericht

16/09 · 2025 Half-year financial information · Persbericht

16/09 · Transgene’s Individualized Neoantigen Therapeutic Cancer Vaccine TG4050 Delivers Positive Randomized Phase I Data  Randomization to be Completed in Phase II Part in Q4 2025 · Persbericht

15/09 · Avidity Biosciences, Inc. Announces Closing of Upsized Public Offering of Common Stock, Including Full Exercise of Underwriters' Option to Purchase Additional Shares · Persbericht

15/09 · Vooruitblik op Amerika · Bolero.be

Voor de bel Amerikaanse futures voorspellen een rustige start van de beursweek. Beleggers kijken vooral uit naar het rentebesluit van de Amerikaanse centrale bank woensdag. De verwachting is dat de Fed haar versoepelingscyclus...

15/09 · Labcorp Completes Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses · Persbericht

15/09 · New data for Kodiak's KSI-101 from the APEX study reinforce its clinically meaningful vision gains and rapid retinal drying in macular edema secondary to inflammation (MESI) · Persbericht

13/09 · INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Capricor Therapeutics · Persbericht

13/09 · INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Replimune · Persbericht

12/09 · Voting Rights and Shares Capital of the Company · Persbericht

12/09 · Alkermes Appoints Joshua Reed as Chief Financial Officer · Persbericht

12/09 · Class Action Filed Against Capricor Therapeutics, Inc. (CAPR) Seeking Recovery for Investors - Contact Levi & Korsinsky · Persbericht

12/09 · Replimune Group, Inc. Class Action: Levi & Korsinsky Reminds Replimune Group, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 22, 2025 - REPL · Persbericht

12/09 · Update on Information Relating to the General Meeting of September 30, 2025 · Persbericht

12/09 · Avidity Biosciences Announces Pricing of Upsized Public Offering of Common Stock · Persbericht

11/09 · OSE Immunotherapeutics and the FoRT Foundation Announce Completion of Enrollment in Combi-TED, a Phase 2 Clinical Trial Evaluating Tedopi® in Combination with Nivolumab or Docetaxel in Patients with Non-Small Cell Cancer · Persbericht

11/09 · Co-Diagnostics, Inc. Performs Analysis of Chikungunya Co-Primers® to Confirm Reactivity Against Known Virus Strains · Persbericht

11/09 · Evofem's "Say Vagina" Campaign Generates More than 2.5 Million Views Across Social Media Platforms · Persbericht

Mijn selecties